{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:59:37Z","timestamp":1774583977555,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400242"],"award-info":[{"award-number":["82400242"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Committee","doi-asserted-by":"publisher","award":["23JCQNJC00870"],"award-info":[{"award-number":["23JCQNJC00870"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2023KJ112"],"award-info":[{"award-number":["2023KJ112"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","award":["TJWJ2024QN008"],"award-info":[{"award-number":["TJWJ2024QN008"]}],"id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06516-0","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T04:30:18Z","timestamp":1746592218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["T-lymphocytes suppression by CD14+ monocytes with high expression of ULK2 in patients with multiple myeloma"],"prefix":"10.1186","volume":"23","author":[{"given":"Fengping","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nianbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanhao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9928-9224","authenticated-orcid":false,"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"6516_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ctrv.2018.09.001","volume":"70","author":"P Robak","year":"2018","unstructured":"Robak P, Drozdz I, Szemraj J, Robak T. Drug resistance in multiple myeloma. Cancer Treat Rev. 2018;70:199\u2013208.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"6516_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","volume":"1","author":"O Zavidij","year":"2020","unstructured":"Zavidij O, Haradhvala NJ, Mouhieddine TH, Sklavenitis-Pistofidis R, Cai S, Reidy M, et al. Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nat Cancer. 2020;1(5):493\u2013506.","journal-title":"Nat Cancer"},{"issue":"3","key":"6516_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3324\/haematol.2016.152504","volume":"102","author":"P Rodr\u00edguez-Otero","year":"2017","unstructured":"Rodr\u00edguez-Otero P, Paiva B, Engelhardt M, Pr\u00f3sper F, San Miguel JF. Is immunotherapy here to stay in multiple myeloma? Haematologica. 2017;102(3):423\u201332.","journal-title":"Haematologica"},{"issue":"12","key":"6516_CR4","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s43018-023-00657-1","volume":"4","author":"F Maura","year":"2023","unstructured":"Maura F, Boyle EM, Coffey D, Maclachlan K, Gagler D, Diamond B, et al. Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens. Nat Cancer. 2023;4(12):1660\u201374.","journal-title":"Nat Cancer"},{"issue":"14","key":"6516_CR5","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1038\/s41467-023-41562-6","volume":"20","author":"C Botta","year":"2023","unstructured":"Botta C, Perez C, Larrayoz M, Puig N, Cedena MT, Termini R, et al. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Nat Commun. 2023;20(14):5825.","journal-title":"Nat Commun"},{"issue":"4","key":"6516_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2023.02.008","volume":"41","author":"MJ Friedrich","year":"2023","unstructured":"Friedrich MJ, Neri P, Kehl N, Michel J, Steiger S, Kilian M, et al. The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients. Cancer Cell. 2023;41(4):711-725.e6.","journal-title":"Cancer Cell"},{"issue":"6","key":"6516_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1158\/2643-3230.BCD-22-0018","volume":"3","author":"KM Dhodapkar","year":"2022","unstructured":"Dhodapkar KM, Cohen AD, Kaushal A, Garfall AL, Manalo RJ, Carr AR, et al. Changes in bone marrow tumor and immune cells correlate with durability of remissions following BCMA CAR T therapy in Myeloma. Blood Cancer Discov. 2022;3(6):490\u2013501.","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"6516_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13045-022-01234-2","volume":"15","author":"M Swamydas","year":"2022","unstructured":"Swamydas M, Murphy EV, Ignatz-Hoover JJ, Malek E, Driscoll JJ. Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma. J Hematol Oncol. 2022;15(1):17.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"6516_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012;12(4):253\u201368.","journal-title":"Nat Rev Immunol"},{"issue":"16","key":"6516_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev-pathmechdis-012418-013058","volume":"24","author":"S Ugel","year":"2021","unstructured":"Ugel S, Can\u00e8 S, De Sanctis F, Bronte V. Monocytes in the Tumor Microenvironment. Annu Rev Pathol. 2021;24(16):93\u2013122.","journal-title":"Annu Rev Pathol"},{"issue":"11","key":"6516_CR11","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.ccell.2022.10.017","volume":"40","author":"R Sklavenitis-Pistofidis","year":"2022","unstructured":"Sklavenitis-Pistofidis R, Aranha MP, Redd RA, Baginska J, Haradhvala NJ, Hallisey M, et al. Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. Cancer Cell. 2022;40(11):1358-1373.e8.","journal-title":"Cancer Cell"},{"issue":"1","key":"6516_CR12","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1038\/s41467-021-26951-z","volume":"12","author":"SM Tirier","year":"2021","unstructured":"Tirier SM, Mallm JP, Steiger S, Poos AM, Awwad MHS, Giesen N, et al. Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics. Nat Commun. 2021;12(1):6960.","journal-title":"Nat Commun"},{"issue":"1","key":"6516_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40164-023-00402-5","volume":"12","author":"W Li","year":"2023","unstructured":"Li W, Zhang B, Cao W, Zhang W, Li T, Liu L, et al. Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed\/refractory multiple myeloma through single-cell sequencing. Exp Hematol Oncol. 2023;12(1):44.","journal-title":"Exp Hematol Oncol"},{"key":"6516_CR14","doi-asserted-by":"publisher","first-page":"1475435","DOI":"10.1155\/2016\/1475435","volume":"2016","author":"S Sprangers","year":"2016","unstructured":"Sprangers S, de Vries TJ, Everts V. Monocyte heterogeneity: consequences for monocyte-derived immune cells. J Immunol Res. 2016;2016:1475435.","journal-title":"J Immunol Res"},{"issue":"7","key":"6516_CR15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.4161\/auto.7.7.15450","volume":"7","author":"EJ Lee","year":"2011","unstructured":"Lee EJ, Tournier C. The requirement of uncoordinated 51-like kinase 1 (ULK1) and ULK2 in the regulation of autophagy. Autophagy. 2011;7(7):689\u201395.","journal-title":"Autophagy"},{"issue":"4","key":"6516_CR16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1182\/bloodadvances.2022008021","volume":"7","author":"CV Edwards","year":"2023","unstructured":"Edwards CV, Hassan H, Yildirim C, Ferri G, Verma KP, Murray Horwitz ME, et al. Peripheral blood monocyte count is a dynamic prognostic biomarker in multiple myeloma. Blood Adv. 2023;7(4):482\u201390.","journal-title":"Blood Adv"},{"issue":"6","key":"6516_CR17","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/cancers13061454","volume":"13","author":"D Damasceno","year":"2021","unstructured":"Damasceno D, Almeida J, Teodosio C, Sanoja-Flores L, Mayado A, P\u00e9rez-Pons A, et al. Monocyte subsets and serum inflammatory and bone-associated markers in monoclonal gammopathy of undetermined significance and multiple myeloma. Cancers (Basel). 2021;13(6):1454.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"6516_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3324\/haematol.2016.153841","volume":"102","author":"M Bolzoni","year":"2017","unstructured":"Bolzoni M, Ronchetti D, Storti P, Donofrio G, Marchica V, Costa F, et al. IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts. Haematologica. 2017;102(4):773\u201384.","journal-title":"Haematologica"},{"issue":"12","key":"6516_CR19","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013001","volume":"12","author":"L Gibellini","year":"2020","unstructured":"Gibellini L, De Biasi S, Paolini A, Borella R, Boraldi F, Mattioli M, et al. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol Med. 2020;12(12): e13001.","journal-title":"EMBO Mol Med"},{"issue":"3","key":"6516_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.immuni.2012.05.029","volume":"37","author":"SM Soudja","year":"2012","unstructured":"Soudja SM, Ruiz AL, Marie JC, Lauvau G. Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity. 2012;37(3):549\u201362.","journal-title":"Immunity"},{"issue":"2020","key":"6516_CR21","first-page":"1835836","volume":"6","author":"P Robak","year":"2020","unstructured":"Robak P, W\u0119g\u0142owska E, Dr\u00f3\u017cd\u017c I, Mikulski D, Jarych D, Ferli\u0144ska M, et al. Cytokine and chemokine profile in patients with multiple myeloma treated with bortezomib. Mediators Inflamm. 2020;6(2020):1835836.","journal-title":"Mediators Inflamm"},{"key":"6516_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155358","volume":"138","author":"J Gu","year":"2021","unstructured":"Gu J, Huang X, Zhang Y, Bao C, Zhou Z, Jin J. Cytokine profiles in patients with newly diagnosed multiple myeloma: survival is associated with IL-6 and IL-17A levels. Cytokine. 2021;138: 155358.","journal-title":"Cytokine"},{"issue":"7","key":"6516_CR23","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1111\/cas.15800","volume":"114","author":"J Jiang","year":"2023","unstructured":"Jiang J, Xiang J, Chen M, Wan Y, Zhong L, Han X, et al. Distinct mechanisms of dysfunctional antigen-presenting DCs and monocytes by single-cell sequencing in multiple myeloma. Cancer Sci. 2023;114(7):2750\u201360.","journal-title":"Cancer Sci"},{"issue":"2","key":"6516_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132\u201341.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"6516_CR25","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1080\/15548627.2021.2022289","volume":"18","author":"MP Harris","year":"2022","unstructured":"Harris MP, Zhang QJ, Cochran CT, Ponce J, Alexander S, Kronemberger A, et al. Perinatal versus adult loss of ULK1 and ULK2 distinctly influences cardiac autophagy and function. Autophagy. 2022;18(9):2161\u201377.","journal-title":"Autophagy"},{"key":"6516_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.732308","volume":"12","author":"JC Drake","year":"2021","unstructured":"Drake JC, Wilson RJ, Cui D, Guan Y, Kundu M, Zhang M, et al. Ulk1, Not Ulk 2, Is required for exercise training-induced improvement of insulin response in skeletal muscle. Front Physiol. 2021;12: 732308.","journal-title":"Front Physiol"},{"issue":"6","key":"6516_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127784","volume":"10","author":"SH Shin","year":"2015","unstructured":"Shin SH, Lee EJ, Chun J, Hyun S, Kang SS. ULK2 Ser 1027 phosphorylation by PKA regulates its nuclear localization occurring through karyopherin beta 2 recognition of a PY-NLS Motif. PLoS ONE. 2015;10(6): e0127784.","journal-title":"PLoS ONE"},{"issue":"12","key":"6516_CR28","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.4161\/auto.26563","volume":"9","author":"SH Ro","year":"2013","unstructured":"Ro SH, Jung CH, Hahn WS, Xu X, Kim YM, Yun YS, et al. Distinct functions of Ulk1 and Ulk2 in the regulation of lipid metabolism in adipocytes. Autophagy. 2013;9(12):2103\u201314.","journal-title":"Autophagy"},{"issue":"11","key":"6516_CR29","doi-asserted-by":"publisher","first-page":"11735","DOI":"10.1096\/fj.201900766R","volume":"33","author":"JD Fuqua","year":"2019","unstructured":"Fuqua JD, Mere CP, Kronemberger A, Blomme J, Bae D, Turner KD, et al. ULK2 is essential for degradation of ubiquitinated protein aggregates and homeostasis in skeletal muscle. FASEB J. 2019;33(11):11735\u201345.","journal-title":"FASEB J"},{"issue":"2","key":"6516_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10120-021-01250-0","volume":"25","author":"I Motoo","year":"2022","unstructured":"Motoo I, Nanjo S, Ando T, Yamashita S, Ushijima T, Yasuda I. Methylation silencing of ULK2 via epithelial-mesenchymal transition causes transformation to poorly differentiated gastric cancers. Gastric Cancer. 2022;25(2):325\u201335.","journal-title":"Gastric Cancer"},{"issue":"21","key":"6516_CR31","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1016\/j.molcel.2021.08.039","volume":"81","author":"JF Linares","year":"2021","unstructured":"Linares JF, Zhang X, Martinez-Ordo\u00f1ez A, Duran A, Kinoshita H, Kasashima H, et al. PKC\u03bb\/\u03b9 inhibition activates an ULK2-mediated interferon response to repress tumorigenesis. Mol Cell. 2021;81(21):4509-4526.e10.","journal-title":"Mol Cell"},{"issue":"1","key":"6516_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/ijms25010646","volume":"25","author":"J Lai","year":"2024","unstructured":"Lai J, Yang C, Shang C, Chen W, Chu MP, Brandwein J, et al. ULK2 is a key pro-autophagy protein that contributes to the high chemoresistance and disease relapse in FLT3-mutated acute Myeloid Leukemia. Int J Mol Sci. 2024;25(1):646.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"6516_CR33","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","volume":"22","author":"N Pishesha","year":"2022","unstructured":"Pishesha N, Harmand TJ, Ploegh HL. A guide to antigen processing and presentation. Nat Rev Immunol. 2022;22(12):751\u201364.","journal-title":"Nat Rev Immunol"},{"key":"6516_CR34","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1038\/s41586-020-2229-5","volume":"581","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto K, Venida A, Yano J, Biancur DE, Kakiuchi M, Gupta S, Sohn AS, Mukhopadhyay S, Lin EY, Parker SJ, Banh RS, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:7806.","journal-title":"Nature"},{"issue":"18","key":"6516_CR35","doi-asserted-by":"publisher","first-page":"11376","DOI":"10.1074\/jbc.C114.627778","volume":"290","author":"KJ Petherick","year":"2015","unstructured":"Petherick KJ, Conway OJL, Mpamhanga C, Osborne SA, Kamal A, Saxty B, et al. Pharmacological Inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy. J Biol Chem. 2015;290(18):11376\u201383.","journal-title":"J Biol Chem"},{"issue":"8","key":"6516_CR36","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1158\/1078-0432.CCR-18-3200","volume":"25","author":"ML Axelrod","year":"2019","unstructured":"Axelrod ML, Cook RS, Johnson DB, Balko JM. Biological consequences of MHC-II expression by tumor cells in cancer. Clin Cancer Res. 2019;25(8):2392\u2013402.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"6516_CR37","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1158\/2326-6066.CIR-22-0227","volume":"10","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Gu SS, Ouardaoui N, Tymm C, Yang L, Wong CJ, et al. Hippo signaling pathway regulates cancer cell-intrinsic MHC-II expression. Cancer Immunol Res. 2022;10(12):1559\u201369.","journal-title":"Cancer Immunol Res"},{"key":"6516_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102329","volume":"83","author":"G Sari","year":"2023","unstructured":"Sari G, Rock KL. Tumor immune evasion through loss of MHC class-I antigen presentation. Curr Opin Immunol. 2023;83: 102329.","journal-title":"Curr Opin Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06516-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06516-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06516-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T04:30:19Z","timestamp":1746592219000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06516-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6516"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06516-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6254013\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics Committee and Experimental Animal Welfare Ethics Committee of Tianjin Medical University General Hospital permitted this project (IRB2023-KY-325, IRB2023-DWFL-397). All participants signed written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"511"}}